News & Updates
Filter by Specialty:
PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer
Adjuvant chemoradiotherapy (CRT) improves both 10-year overall survival (OS) and recurrence-free survival (RFS) in women with high-risk endometrial cancer vs pelvic radiotherapy alone, with the most clinically relevant benefit observed in p53 abnormal cancers, according to the 10-year analysis of the phase III PORTEC-3 trial.
PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer
15 Sep 2025
What’s hot at APS & MCV 2025?
MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]
What’s hot at APS & MCV 2025?
15 Sep 2025
Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI
A significant association exists between a reduced apical rotation and functional mitral regurgitation in patients with acute ST-elevation myocardial infarction (MI), suggesting a potential novel pathophysiological mechanism, reports a study.